Gene signatures of cDC1 have been associated with a favorable prognosis in multiple human cancer types (47, 66, 68), including breast cancer, melanoma, head and neck squamous cell carcinoma, and lung adenocarcinoma. Here, MPPE1 is linked to melanoma.